IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Indo US Bio-Tech IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 7.29 Cr. The company is based in Ahmedabad and caters to Agro - Food Products sector. Swastika Investmart is the merchant banker of Indo US Bio-Tech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th March 2018.
Indo US Bio-Tech IPO open date is 30th April 2018 and close date is 3rd May 2018. IPO Allotment Date is [●] and Listing date is 11th May 2018.
IPO
Size:
₹ 7.29 Cr.
Avg IPO Size (Sector Based)
: ₹
19.03 cr.
Sector: Agro - Food Products
SME
IPO so far:
32
Merchant Banker:
Swastika Investmart
SME
IPO by BRLM so far:
34
City:
Ahmedabad
SME
IPO so far:
180
Revenue (annualised):
₹
27.15
cr. 
PE
Ratio:
19.00x
Average Sector PE Ratio: 19.17x
Indo US Bio-Tech IPO size is ₹ 7.29 Cr. with IPO price of ₹ 51.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Swastika Investmart Limited is the book-running lead manager of the Indo US Bio-Tech IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Beeline Broking Limited for Indo US Bio-Tech IPO.
Indo US Bio-Tech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Indo US Bio-Tech IPO, based in Ahmedabad, operates in the Agro - Food Products sector with a focus on business of breeding products. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Indo US Bio-Tech IPO size is ₹ 7.29 Cr. with fresh issue size of ₹ 7.29 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Indo US Bio-Tech IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Indo US Bio-Tech IPO allotment status on the registrars website, Bigshare Services Private Limited . Indo US Bio-Tech IPO refund dates are [●].
Indo US Bio-Tech IPO is expected to be listed on 11th May 2018.
The upper price band for the Indo US Bio-Tech IPO is set at ₹ 51.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Indo US Bio-Tech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Indo US Bio-Tech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 3rd May 2018. After submission, funds are blocked until the basis of allotment of Indo US Bio-Tech IPO is finalised.
The merchant banker for Indo US Bio-Tech IPO is Swastika Investmart Limited . Swastika Investmart Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Indo US Bio-Tech IPO RHP for further details.
The registrar for Indo US Bio-Tech IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Indo US Bio-Tech IPO through their official website or helpline.
Indo US Bio-Tech IPO was subscribed 19.74 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 7.29 Cr.
Avg IPO Size (Sector Based)
:
₹ 19.03 Cr.
Sector: Agro - Food Products
SME
IPO so far:
32
Merchant Banker:
Swastika Investmart
SME
IPO by BRLM so far:
34
City:
Ahmedabad
SME
IPO so far:
180
Revenue (annualised):
₹ 27.15 cr.
PE
Ratio:
19.00x
Average Sector PE Ratio: 19.17x
Indo US Bio-Tech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Indo US Bio-Tech Financial Review Page
Merchant Banker(s) of Indo US Bio-Tech IPO: Swastika Investmart Limited
Indo US Bio-Tech IPO subscription was 19.74 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Indo US Bio-Tech IPO listed at a listing price of 57.80 against the offer price of 51.00.
The current market price of Indo US Bio-Tech is 154.63.
Why Us?
